mdxhealth

mdxhealth

生物技术研究

Irvine,CA 6,894 位关注者

Molecular Diagnostic Solutions for Prostate Cancer

关于我们

Mdxhealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The Company's European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California.

所属行业
生物技术研究
规模
51-200 人
总部
Irvine,CA
类型
上市公司
创立
2003
领域
Molecular Diagnostics、Methylation、Cancer、Next Generation Sequencing、pharmaceutical and diagnostic products和medical devices

地点

mdxhealth员工

动态

关联主页

相似主页

查看职位

融资

mdxhealth 共 9 轮

上一轮

上市后股权

US$40,000,000.00

Crunchbase 上查看更多信息